Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015.
作者信息
Halota Waldemar, Flisiak Robert, Boroń-Kaczmarska Anna, Juszczyk Jacek, Pawłowska Małgorzata, Simon Krzysztof, Tomasiewicz Krzysztof, Małkowski Piotr
出版信息
Clin Exp Hepatol. 2015 Nov;1(3):97-104. doi: 10.5114/ceh.2015.55566. Epub 2015 Nov 16.
Abstract
摘要
相似文献
1
Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015.丙型肝炎治疗建议。波兰丙型肝炎专家小组 - 2015年。
Clin Exp Hepatol. 2015 Nov;1(3):97-104. doi: 10.5114/ceh.2015.55566. Epub 2015 Nov 16.
2
Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2020.2020年波兰丙型肝炎专家小组关于丙型肝炎治疗的建议。
Clin Exp Hepatol. 2020 Sep;6(3):163-169. doi: 10.5114/ceh.2020.98606. Epub 2020 Sep 1.
3
Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023.2023年波兰丙型肝炎专家小组关于丙型肝炎治疗的建议。
Clin Exp Hepatol. 2023 Mar;9(1):1-8. doi: 10.5114/ceh.2023.125957. Epub 2023 Mar 24.
4
Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts - 2016.波兰丙型肝炎专家小组发布的丙型肝炎治疗建议 - 2016年
Clin Exp Hepatol. 2016 Jun;2(2):27-33. doi: 10.5114/ceh.2016.59099. Epub 2016 Apr 7.
5
Recommendations for the treatment of hepatitis C Polish group of HCV Experts--2015.
Przegl Epidemiol. 2015;69(3):515-21, 625-31.
6
Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.老年人乙型肝炎病毒和丙型肝炎病毒感染的血清流行率：波兰全国性调查——PolSenior。
Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1288-95. doi: 10.1097/MEG.0b013e328357632a.
7
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明：2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
8
Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020.评估实体器官捐献者和监测人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒感染的移植受者-美国卫生与公众服务部 2020 年指南。
MMWR Recomm Rep. 2020 Jun 26;69(4):1-16. doi: 10.15585/mmwr.rr6904a1.
9
The prevalence of mixed genotype infections in Polish patients with hepatitis C.波兰丙型肝炎患者混合基因型感染的流行率。
Int J Infect Dis. 2016 Feb;43:13-16. doi: 10.1016/j.ijid.2015.12.007. Epub 2015 Dec 14.
10
[Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].[1994 - 2003年波兰献血者中丙型肝炎病毒标志物的流行情况]
Przegl Epidemiol. 2005;59(4):807-14.
引用本文的文献
1
The burden of viral hepatitis infection and mortality: Findings from a population-based study in Poland over 2009-2023.病毒性肝炎感染和死亡率负担：2009年至2023年波兰一项基于人群研究的结果
Clin Exp Hepatol. 2025 Jun;11(2):137-146. doi: 10.5114/ceh.2025.151703. Epub 2025 Jun 26.
2
Real-world experience with ombitasvir/paritaprevir boosted with ritonavir and possibly combined with dasabuvir and ribavirin in HCV infection.在丙型肝炎病毒感染中，使用利托那韦增强的奥比他韦/帕利瑞韦，并可能联合达沙布韦和利巴韦林的真实世界经验。
Clin Exp Hepatol. 2016 Jun;2(2):34-37. doi: 10.5114/ceh.2016.60247. Epub 2016 Jun 6.
3
Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts - 2016.波兰丙型肝炎专家小组发布的丙型肝炎治疗建议 - 2016年
Clin Exp Hepatol. 2016 Jun;2(2):27-33. doi: 10.5114/ceh.2016.59099. Epub 2016 Apr 7.
4
Evaluation of hepatic fibrosis - access to non-invasive methods, national practice/guidelines in Central Europe.肝纤维化评估——中欧地区非侵入性方法的应用、国家实践/指南
Clin Exp Hepatol. 2016 Mar;2(1):12-15. doi: 10.5114/ceh.2016.58851. Epub 2016 Mar 24.
本文引用的文献
1
Natural history of hepatitis C.丙型肝炎的自然史。
J Hepatol. 2014 Nov;61(1 Suppl):S58-68. doi: 10.1016/j.jhep.2014.07.012. Epub 2014 Nov 3.
2
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study.达拉他韦联合asunaprevir 治疗 1b 型丙型肝炎病毒：一项多中心、3 期、多队列研究。
Lancet. 2014 Nov 1;384(9954):1597-605. doi: 10.1016/S0140-6736(14)61059-X. Epub 2014 Jul 28.
3
EASL recommendations on treatment of hepatitis C 2014.2014年欧洲肝脏研究学会丙型肝炎治疗指南
J Hepatol. 2014 Aug;61(2):373-95. doi: 10.1016/j.jhep.2014.05.001. Epub 2014 May 10.
4
Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection.达拉他韦联合阿舒瑞韦治疗慢性丙型肝炎1b型感染。
Hepatology. 2014 Jun;59(6):2083-91. doi: 10.1002/hep.27113. Epub 2014 Apr 1.
5
Distribution of HCV genotypes in Poland.波兰丙型肝炎病毒基因型的分布情况。
Przegl Epidemiol. 2013;67(1):11-6, 99-103.
6
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.慢性丙型肝炎合并晚期肝纤维化患者持续病毒学应答与全因死亡率的关系。
JAMA. 2012 Dec 26;308(24):2584-93. doi: 10.1001/jama.2012.144878.
7
[Standards of hepatitis C treatment. Recommendations of Polish Group of Experts].[丙型肝炎治疗标准。波兰专家小组的建议]
Przegl Epidemiol. 2012;66(1):83-8.
8
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.肝癌肝移植治疗的推荐：国际共识会议报告。
Lancet Oncol. 2012 Jan;13(1):e11-22. doi: 10.1016/S1470-2045(11)70175-9. Epub 2011 Oct 31.
9
Prevalence and risk factors of HCV infection in Poland.波兰丙型肝炎病毒感染的流行情况和危险因素。
Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1213-7. doi: 10.1097/MEG.0b013e32834d173c.
10
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.欧洲、加拿大和以色列丙型肝炎病毒流行病学的系统评价。
Liver Int. 2011 Jul;31 Suppl 2:30-60. doi: 10.1111/j.1478-3231.2011.02539.x.
Zotero 插件